Radiotherapy of bone metastasis in breast cancer patients - Current approaches

Breast Care

Volumn 7, Issue 2, 2012, Pages 108-112

  Feyer, Petra C ^a   Steingraeber, Maria ^b  

^a VIVANTES KLINIKUM NEUKÖLLN   (Germany)

^b Gemeinschaftspraxis für Strahlentherapie und Radioonkologie   (Germany)

Author keywords

Bone metastasis; Breast cancer, metastatic; Radiotherapy

Indexed keywords

ANTIEMETIC AGENT; ETIDRONIC ACID RE 186; LEXIDRONAM SAMARIUM SM 153; RHENIUM; STRONTIUM CHLORIDE SR 89;

ANALGESIA; BONE MARROW TOXICITY; BONE METASTASIS; BONE PAIN; BREAST CALCIFICATION; BREAST CANCER; CANCER CONTROL; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; DIARRHEA; DISEASE COURSE; HUMAN; NAUSEA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RADIATION INJURY; REVIEW; SPINAL CORD COMPRESSION; SURVIVAL RATE; TREATMENT INDICATION; VOMITING;

EID: 84861376759     PISSN: 16613791     EISSN: 16613805     Source Type: Journal    
DOI: 10.1159/000338724     Document Type: Review

References (39)

1. Amichetti M, Orru P, Madeddu A et al.: Comparative evaluation of two hypofractionated radiotherapy regimes for painful bone metastases. Tumori 2004;90(1):91-5.
2. Frassica DA: General principles of external beam radiation therapy for skeletal metastases. Clin Orthop Relat Res 2003;415:158-64.
3. Diel IJ, Solomayer EF, Bastert G: Treatment of metastatic bone disease in breast cancer: bisphosphonates. Clin Breast Cancer 2000;1(1):43-51.
4. Hoskin PJ: Bisphosphonates and radiation therapy for palliation of metastastic bone disease. Cancer Treat Rev 2003;29(4):321-7.
5. Diel IJ, Feyer P: Knochenmetastasen-Vermeidungskelettaler Komplikationen. Focus Onkol 2011;14 (9):54-60.
6. Souchon R, Wenz F, Sedlmayer F et al.: DEGRO practice guidelines for palliative radiotherapy of metastastic breast cancer-bone metastases and metastatic spinal cord compression. Strahlenther Onkol 2009;185:417-24.
7. AGO breast committee: Diagnosis and treatment of patients with primary and metastatic breast cancer. Recommondations 2012. Version 2012.1. www.ago-online.de.
8. Souchon R, Feyer P, Thomssen C et al.: Clinical recommendations of DEGRO and AGO on preffered standard palliative radiotherapy of bone and cerebral metastases, metastatic spinal cord compression, and leptomeningeal carcinomatosis in breast cancer. Breast Care 2010;5:401-07.
9. Wu JS, Wong RK, Lloyd NS et al.: Radiotherapy fractionation for the palliation of uncomplicated painful bone metastases-an evidence based practice guideline. BMC Cancer 2004;4(1):71.
10. Wai MS, Micke S, Ines H et al.: Palliation of metastatic bone pain: single fraction versus multi fraction radiotherapy-a systematic review of the randomised trials. Chochrane Datab Syst Rev 2004;2:CD004721.
11. Van der Linden YM, Lok JJ, Steenland E et al.:Single fraction radiotherapy is efficacious: a further analysis of the Dutch Bone Metastasis Study controlling for the influence of retreatment. Int J Radiat Oncol Biol Phys 2004;59(2):528-37.
12. Shakespeare TP, Lu JJ, Back MF et al.: Patient preference for radiotherapy fractionation schedule in the palliation of painful bone metastases. J Clin Oncol 2003;21(11):2156-62.
13. Van der Linden YM, Dijkstra SP, Vonk EJ et al.: Prediction on survival in patients with metastases in the spinal column: results based on a randomized trial of radiotherapy. Cancer 2005;103(2):320-8.
14. Rades D, Panzner A, Rudat V et al.: Dose escalation of radiotherapy for metastatic spinal cord compression (MSCC) in patients with relatively favorable survival prognosis. Strahlenther Onkol 2011;187(11):729-35.
15. Kouloulias EV, Kouvaris RJ, Antypas C et al.: An intra-patient dose escalation study of disodium pamidronate plus radiotherapy versus radiotherapy alone for the treatment of osteolytic metastasis. Monitoring of recalcification using image-processing techniques. Strahlenther Onkol 2003;179(7):471-9.
16. Loblaw DA, Laperriere NJ: Emergency treatment of malignant extradural spinal cord compression: an evidence-based guideline. J Clin Oncol 1998;16(4):1613-24.
17. Loblaw DA, Perry J, Chambers A et al.: Systematic review of the diagnosis and management of malignant extradural spine cord compression: The Cancer Care Ontario Practice Guidelines Initiatives Neuro-Oncology Disease Site Group. J Clin Oncol 2005;23:2028-37.
18. Helweg-Larsen S, Sorensen PS, Kreiner S: Prognostic factors in metastatic spinal cord compression: a prospective study using multivariate analysis of variables influencing survival and gait function in 153 patients. Int J Radiat Oncol Biol Phys 2000;46(5):1163-9.
19. Kida A, Taniguchi S, Fukuda H et al.: Radiation therapy for metastatic spinal tumors. Radiat Med 2000;18(1):15-20.
20. Rades D, Karstens JH: A comparison of two different radiation schedules for metastatic spinal cord compression considering a new prognostic factor. Strahlenther Onkol 2002;178(10):556-61.
21. Schnabel K, Niewald M, Nestle U et al.: Perkutane Strahlentherapie von Knochenmetastasen; in Zamboglou N: Radioonkologische Aspekte in der palliativen Tumortherapie. Germering, Zuckschwerdt 1995, p 15.
22. Patchell RA, Tibbs PA, Regine WF et al.: Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet 2005;366(9486):643-8.
23. Rades D, Veninga T, Stalpers LJ et al.: Prognostic factors predicting functional outcomes, recurrence free survival, and overall survival after radiotherapy for metastatic spinal cord compression in breast cancer patients. Int J Radiat Oncol Biol Phys 2006;64(1):182-8.
24. Rades D, Stalpers LJ, Veninga T et al.: Evaluation of five radiation schedules and prognostic factors for metastastic spinal cord compression. J Clin Oncol 2005;23 (15):3366-75.
25. Rades D, Karstens JH, Alberti W: Role of radiotherapy in the treatment of motor dysfunction due to metastatic spinal cord compression: comparison of three different fractionation schedules. Int J Radiat Oncol Biol Phys 2002;54(4):1160-4.
26. Rades D, Rudat V, Veninga T et al.: A score predicting posttreatment ambulatory status in patients irradiated for metastatic spinal cord compression. Int J Radiat Oncol Biol Phys 2008;72(3):905-8.
27. Rades D, Lange M, Veninga T et al.: Final results of prospective study comparing the local contral of short-course and long-course radiotherapy for metastastic spinal cord compression. Int J Radiat Oncol Biol Phys 2011;79(2): 524-30.
28. Rades D, Panzner A, Rudat V et al.: Dose escalation of radiotherapy for metastatic spinal cord compression (MSCC) in patients with relatively favourable survival prognosis. Strahlenther Onkol 2011;187(11):729-35.
29. Sarin R, Budrukkar A: Efficacy, toxicity, and costeffectiveness of single-dose versus fractionated hemibody irradiation (HBI). Int J Radiat Oncol Biol Phys 2002;52(4):1146-7.
30. Skolyszewski J, Sas-Korczynska B, Korzeniowski Set al.: The efficiency and tolerance of half-body irradiation in patients with multiple metastasis. The Krakow experience. Strahlenther Onkol 2001;9:482-6.
31. Miszczyk L, Tukiendorf A, Gaborek A, Wydmaski J:An evaluation of half-body irradiation in the treatment of widespread, painful metastatic bone disease. Tumori 2008;94(6):813-21.
32. Salazar OM, Sandhu T, da Motta NW et al.: Fractionated half-body irradiation (HBI) for the rapid palliation of widespread, symptomatic, metastatic bone disease: a randomized phase III trial of the International Atomic Energy Agency (IAEA). Int J Radiat Oncol Biol Phys 2001;50(3):765-75.
33. Heron DE, Brufsky A, Beriwal S et al.: Myelotoxicity of samarium Sm 153 lexidronam in patients receiving prior treatment with chemotherapy or radiotherapy. Ann Oncol 2008;19(9):1639-43.
34. Falkmer U, Järhult J, Wersäll P et al.: A systematic overview of radiation therapy effects in skeletal metastases. Acta Oncol 2003;42(5-6):620-33.
35. Leondi AH, Souvatzoglou MA, Rapti AS et al.: Palliative treatment of painful disseminated bone metastases with 186Rhenium-HEDP in patients with lung cancer. Q J Nucl Med Mol Imaging 2004;48(3):211-9.
36. Feyer PC, Maranzano E, Molassiotis A et al.: Radiotherapy induced nausea and vomiting (RINV): MASCC/ESMO guideline for antiemetics in radiotherapy: update 2009. Support Care Cancer 2010;19(1):5-14.
37. Basch E, Presturd AA, Hesketh PJ et al.: Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol 2011;29(31):4189-98.
38. Lutz S, Berg L, Chang E et al.: Palliative radiotherapy for bone metastases: An ASTRO evidencebased guideline. Int J Radiat Oncol Biol Phys 2011;79(4):965-76.
39. Van Oorschot B, Beckmann G, Schulze B et al.: Radiotherapeutic options for symptom control in breast cancer. Breast Care 2011;6:14-9.